chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: High fever; Nausea; Vomiting; Dizziness; Exhaustion; Headaches; Lost of appetite; Heart palpitations; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 29Mar2021 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included escitalopram (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient previously took tetracycline (MANUFACTURER UNKNOWN) for an unknown indication on an unspecified date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 08Mar2021 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 29Mar2021 at 18:00, the patient experienced high fever, nausea, vomiting, dizziness, exhaustion, headaches, lost of appetite and heart palpitations. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date in Apr2021, the patient underwent nasal swab COVID-19 test and the result was negative. The clinical outcome of the events high fever, nausea, vomiting, dizziness, exhaustion, headaches, lost of appetite and heart palpitations was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Pyrexia, SARS-CoV-2 test, Vomiting
Clinical narrative: High fever; Nausea; Vomiting; Dizziness; Exhaustion; Headaches; Lost of appetite; Heart palpitations; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 29Mar2021 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included escitalopram (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient previously took tetracycline (MANUFACTURER UNKNOWN) for an unknown indication on an unspecified date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 08Mar2021 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 29Mar2021 at 18:00, the patient experienced high fever, nausea, vomiting, dizziness, exhaustion, headaches, lost of appetite and heart palpitations. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date in Apr2021, the patient underwent nasal swab COVID-19 test and the result was negative. The clinical outcome of the events high fever, nausea, vomiting, dizziness, exhaustion, headaches, lost of appetite and heart palpitations was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Gingival bleeding, Headache, Palpitations
Clinical narrative: Gum bleeding; dizziness; light headaches; ears ring; palpitations; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 09Apr2021 at 16:45 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 17:00 the patient experienced gum bleeding, dizziness, light headaches, ears ring, palpitations and tiredness. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcomes of the events gum bleeding, dizziness, light headaches, ears ring, palpitations and tiredness were not recovered.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Gum bleeding; dizziness; light headaches; ears ring; palpitations; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 09Apr2021 at 16:45 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 17:00 the patient experienced gum bleeding, dizziness, light headaches, ears ring, palpitations and tiredness. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcomes of the events gum bleeding, dizziness, light headaches, ears ring, palpitations and tiredness were not recovered.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Myalgia, Pain, Pain in extremity
Clinical narrative: Fatigue; Arm soreness; Muscle aches; General ill-feeling; Pain when moving; This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729), via an unspecified route of administration in the left arm on 09Apr2021 at 10:15 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome and penicillin allergy. Concomitant medications included escitalopram oxalate (LEXAPRO) from an unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 10:30, the patient experienced fatigue, arm soreness and pain when moving, muscle aches and general ill feeling. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events fatigue, arm soreness and pain when moving, muscle aches and general ill feeling were resolving at the time of reporting.   No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Tinnitus
Clinical narrative: Dizziness; Loud ringing in ears; This is a spontaneous report from a non-contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 09Apr2021 at 12:30 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications were not reported. The patient previously received DPT shot (MANUFACTURER UNKNOWN), Novocaine (MANUFACTURER UNKNOWN) and morphine (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient previously received first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 19Mar2021 at 12:30 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 07:30, the patient experienced dizziness and loud ringing in ears. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit.  Therapeutic measures were not taken as a result of the events. The clinical outcome of the events dizziness and loud ringing in ears was recovered on an unknown date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain in extremity
Clinical narrative: Sore throat; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0153) via an unspecified route of administration in the left arm on 08Apr2021 at 16:45 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included CVID (common variable immunodeficiency), WM and allergy to peanuts and quinolones. Concomitant medications included atenolol (MANUFACTURER UNKNOWN) , simvastatin (MANUFACTURER UNKNOWN) and losartan potassium (LOSARTIN) for unknown indication and from unknown dates within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534) via an unspecified route of administration in the left arm on 17Mar2021 at 16:45  (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 09Apr2021 at 06:00, the patient experienced sore throat and sore arm. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. The clinical outcome of the event sore throat and sore arm was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: Raw patch of skin on my stomach with a small rash, mostly painful; Slightly itchy; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the right arm on 07Apr2021 at 17:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma from an unknown date. It was unknown whether the patient had known allergies to medications, food or other products. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the right arm on 10Mar2021 at 17:15(at the age of 48-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 08Apr2021 at 15:00 the patient experienced raw patch of skin on stomach with a small rash. Slightly itchy but mostly painful. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events raw patch of skin on stomach with a small rash, slightly itchy but mostly painful was not resolved at the time of report.   No follow-up attempts are needed, information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Dyspnoea, Headache, Pain assessment
Clinical narrative: chest itching; shortness of breath; headache to front of head; elevated blood pressure at 169/92; This is a spontaneous report from a contactable other HCP.  A 54-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE)  intramuscular, administered in arm left, on 13Apr2021 12:47 (at the age of 54-year-old) (Lot Number: EN6200) as single dose for COVID-19 immunisation. Relevant medical history included chronic obstructive pulmonary disease, hypertension and cardiac failure congestive. The patient was not pregnant.  Concomitant medications included acetylsalicylic acid (ASPRIN); ciclesonide (ALVESCO); levosalbutamol hydrochloride (XOPENEX); all taken for unspecified indications, start and stop dates were not reported. The patient received vaccination at 12:47pm and began to have chest itching and shortness of breath at 12:53pm; the patient then came to clinic with elevated blood pressure at 169/92 and headache to front of head, 7/10 pain scale. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient received treatment with paracetamol (TYLENOL) for headache. The patient had not recovered from the events. The patient did not have COVID-19 prior to vaccination; the patient was not tested for COVID-19 post vaccination.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: chest itching; shortness of breath; headache to front of head; elevated blood pressure at 169/92; This is a spontaneous report from a contactable other HCP.  A 54-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE)  intramuscular, administered in arm left, on 13Apr2021 12:47 (at the age of 54-year-old) (Lot Number: EN6200) as single dose for COVID-19 immunisation. Relevant medical history included chronic obstructive pulmonary disease, hypertension and cardiac failure congestive. The patient was not pregnant.  Concomitant medications included acetylsalicylic acid (ASPRIN); ciclesonide (ALVESCO); levosalbutamol hydrochloride (XOPENEX); all taken for unspecified indications, start and stop dates were not reported. The patient received vaccination at 12:47pm and began to have chest itching and shortness of breath at 12:53pm; the patient then came to clinic with elevated blood pressure at 169/92 and headache to front of head, 7/10 pain scale. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient received treatment with paracetamol (TYLENOL) for headache. The patient had not recovered from the events. The patient did not have COVID-19 prior to vaccination; the patient was not tested for COVID-19 post vaccination.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Illness, Lymphadenopathy
Clinical narrative: Lump/red circle on arm; "3 days stiff arm"; Scratchy throat; "sore throat with swollen glands"; "sore throat with swollen glands"; Sick; Headache; Cough; Vomiting; Nausea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 08Apr2021 at 10:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included the patient had unspecified allergies to food, medications, or other products. The patient had not received any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications or vaccines within 4 weeks prior to the vaccination. On 08Apr2021 at 15:00, the patient experienced lump/red circle on arm- 3days stiff arm, headache, scratchy throat, sore throat with swollen glands, cough, headache x3 days, vomiting/nausea, fatigue and sick for 3 days plus. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were taken as a result of the adverse events and included treatment with Zofran from unknown date. The clinical outcome of the events lump/red circle on arm, stiff arm, headache, scratchy throat, sore throat with swollen glands, cough, headache, vomiting, nausea, fatigue and sick were recovering at the time of this report.    No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Mass, Musculoskeletal stiffness, Nausea, Oropharyngeal discomfort, Oropharyngeal pain
Clinical narrative: Lump/red circle on arm; "3 days stiff arm"; Scratchy throat; "sore throat with swollen glands"; "sore throat with swollen glands"; Sick; Headache; Cough; Vomiting; Nausea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 08Apr2021 at 10:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included the patient had unspecified allergies to food, medications, or other products. The patient had not received any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications or vaccines within 4 weeks prior to the vaccination. On 08Apr2021 at 15:00, the patient experienced lump/red circle on arm- 3days stiff arm, headache, scratchy throat, sore throat with swollen glands, cough, headache x3 days, vomiting/nausea, fatigue and sick for 3 days plus. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were taken as a result of the adverse events and included treatment with Zofran from unknown date. The clinical outcome of the events lump/red circle on arm, stiff arm, headache, scratchy throat, sore throat with swollen glands, cough, headache, vomiting, nausea, fatigue and sick were recovering at the time of this report.    No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Lump/red circle on arm; "3 days stiff arm"; Scratchy throat; "sore throat with swollen glands"; "sore throat with swollen glands"; Sick; Headache; Cough; Vomiting; Nausea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 08Apr2021 at 10:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included the patient had unspecified allergies to food, medications, or other products. The patient had not received any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications or vaccines within 4 weeks prior to the vaccination. On 08Apr2021 at 15:00, the patient experienced lump/red circle on arm- 3days stiff arm, headache, scratchy throat, sore throat with swollen glands, cough, headache x3 days, vomiting/nausea, fatigue and sick for 3 days plus. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were taken as a result of the adverse events and included treatment with Zofran from unknown date. The clinical outcome of the events lump/red circle on arm, stiff arm, headache, scratchy throat, sore throat with swollen glands, cough, headache, vomiting, nausea, fatigue and sick were recovering at the time of this report.    No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes virus infection
Clinical narrative: Herpes; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: unknown) via an unspecified route of administration in the left arm on 08Apr2021 at 16:00(at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included herpes and celiac disease. The patient had no allergies to medications, food, or other product. The patient did not receive any other medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine.  On an unknown date in Apr2021, the patient reported that the vaccine triggered an intense outbreak of herpes. Therapeutic measures were taken as a result of the event and included treatment with VALTREX. The event resulted in emergency room/department or urgent care. The clinical outcome of herpes was ongoing at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pruritus
Clinical narrative: Full body itching; Slight headache; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), via an unspecified route of administration in left arm on 06Apr2021 at 15:00 (at the age of 54-years-old) as single dose for COVID-19 immunisation. Medical history included diabetic, hyper tension, penicillin allergy and bee pollen allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included enalapril maleate (VASOTEC) and metformin (MANUFACTURER UNKNOWN); both from unknown dates and for unknown indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 06Apr2021 at 16:30, the patient experienced full body itching and slight headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event headache which included treatment with TYLENOL. The clinical outcome of the events full body itching and slight headache were recovered on an unspecified date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Disorientation, Fatigue, Malaise
Clinical narrative: Tired; Feeling Unwell; Somewhat of a disoriented feeling; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 13Apr2021 at 10:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient had medical history of known allergies to penicillin (PCN) (MANUFACTURER UNKNOWN). Concomitant medications included acetylsalicylic acid (ASPIRIN), from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the right arm on 16Mar2021 at 10:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Apr2021 at 14:00, the patient experienced tired, feeling unwell and somewhat of a disoriented feeling. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as the result of reported events. The clinical outcomes of tired, feeling unwell and somewhat of a disoriented feeling were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspepsia
Clinical narrative: heartburn; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: ER8731) via an unspecified route of administration in the left arm on 13Apr2021 at 18:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, temporomandibular joint syndrome, sulfonamide allergy, allergy nos(allergy to   various topical chemical) and heartburn. Concomitant medications included levocetirizine dihydrochloride (XYZALL), rosuvastatin calcium (CRESTOR), melatonin (MANUFACTURER UNKNOWN), doxepin hydrochloride (SILENOR), desogestrel, ethinylestradiol (VIORELE), d and vitamin b complex; all from unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:EN6208) via an unspecified route of administration in the right arm on 22Mar2021 at 18:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 03:00, the patient experienced heartburn starting 9-10 hours post injection. She had heartburn before, so this could be unrelated to the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures taken for the reported events were unknown. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event heartburn was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue
Clinical narrative: Tiredness; Chills; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735), via an unspecified route of administration in the left arm on 11Apr2021 at 12:00 (at the age of 66-years-old), as a single dose for COVID-19 immunisation. Medical history included type II diabetes, factor 5 leiden and COVID-19. The patient did not have any allergies to medications, food or other products. Concomitant medications included metformin (METFORMIN), vitamin d nos (VITAMIN D) and sitagliptin phosphate (JANUVIA); all from unknown dates for unspecified indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021, the patient experienced tiredness and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent SARS-CoV-2 test (nasal swab) and the result was negative. The clinical outcome of the events tiredness and chills were resolving at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Limb discomfort, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Arm and hand with feeling of numbness and heaviness; Arm and hand with feeling of numbness and heaviness; site where the vaccine was applicated became red and swollen, with pain; site where the vaccine was applicated became red and swollen, with pain; site where the vaccine was applicated became red and swollen, with pain; This is a spontaneous report from a non-contactable consumer (patient herself) received from the COVAES portal.  A 35-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection; Lot Number: Ep7533; Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 05Apr2021 15:00 (at the age of 35-year-old), as single dose for covid-19 immunization. Medical history included allergic rhinitis from an unknown date and unknown if ongoing, and known allergies to cats, dogs and mites from an unknown date and unknown if ongoing. Concomitant medications were not reported. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. On 11Apr2021, the patient experienced arm and hand with feeling of numbness and heaviness, and after a week the site where the vaccine was applicated became red and swollen, with pain. The patient did not receive treatment for the resulted events. The outcome of events was reported as not recovered.  No follow-up attempts were needed. No further information was expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Pain in extremity
Clinical narrative: Pain in upper back; Pain between shoulder blades.; Sharp pains when I lift arms, while walking; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 09:45 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis of neck. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took Cipro and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 12:00, the patient experienced pain in upper back, between shoulder blades and thought she pulled the muscles in her back and sharp pains when she lift arms, while walking. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as the result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain in upper back, between shoulder blades and sharp pains when lift arms, while walking was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Petechiae
Clinical narrative: noticed a small case of Petechiae on the inside of her upper left arm; This is a spontaneous report from a contactable consumer, the parent. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 15:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included mild blood disorder, a family history/genetic disposition. Patient had no known allergies. Concomitant medications included nasal spray (MANAFACTURER UNKNOWN) from an unknown date for allergies. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 15:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 11:00, the patient experienced small case of petechiae on the inside of upper left arm. It was reported that patient's mother had cases of petechiae in the past due to her ITP which had a chronic case prior to having two children. After each pregnancy her platelet count improved and she no longer had ITP since her count was within range on the low end. She was watching news carefully regarding side effects and heard about potential bruising. She told her immediate and extended family to be aware of this, since they had a genetic disposition towards bruising. Two of parent's nieces one who received Moderna vaccine and other who received J and J both had bruising in legs and feet. Told them to report their adverse events to the CDC. All 3 of these adverse events were very mild cases. She stated to have pictures to share of patient's case. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event petechiae on the inside of upper left arm was recovering.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness several minutes after injection; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 06Apr2021 at 16:30 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, type 2 diabetes mellitus, function liver abnormal and carotid artery disease. The patient previously took ciprofloxacin on an unknown date for unknown indication and experienced allergy. The patient did received medication within two weeks of vaccination which are not specified. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 several minutes after injection the patient experienced dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event dizziness was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Chronic Rash a lot all over legs, some on arms, some on back, butt, chest; Chronic Rash(hives) a lot all overlegs, some on arms, some on back,butt, chest; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6208), via an unspecified route of administration in the left arm on 12Mar2021(at the age of 52-years-old), as a single dose for COVID-19 immunisation. Medical history included stage 3 kidney disease. Concomitant medications included losartan potassium (MANUFACTURER UNKNOWN) tablet 50 mg from an unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, the patient experienced chronic rash (hives) a lot all over legs, some on arms, some on back, butt, chest. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with hydroxyzine hcl 25 mg and triamcinolone acetonide. The clinical outcome of the event chronic rash(hives) a lot all over legs, some on arms, some on back, butt, chest was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: gland in armpit got very swollen.; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 12Apr2021 at 12:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes from unknown and unknown if ongoing. Concomitant medications included metformin (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC) and daily multivitamin (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via unspecified route of administration in the right arm on 22Mar2021 at 12:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 13Apr2021 at 15:00, the patient experienced gland in her armpit got very swollen. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. The clinical outcome of the event gland in armpit got very swollen was unknown.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Very enlarged lymph nodes under thearm where the vaccine wasadministered; tenderness, and swollenlymph nodes.; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 01Apr2021 at 12:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 18:00, the patient had very enlarged lymph nodes under the arm where the vaccine was administered, tenderness and swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of events enlarged lymph nodes under the arm, tenderness, and swollen lymph nodes which included treatment with Tylenol and hot compresses. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events enlarged lymph nodes under the arm, tenderness and swollen lymph node in left underarm was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Feeling hot, Gait disturbance, Headache, Hypoaesthesia
Clinical narrative: numbness and tingling in 4th and 5th fingers on both hands and heavy feeling legs; numbness and tingling in 4th and 5th fingers on both hands and heavy feeling legs; numbness and tingling in 4th and 5th fingers on both hands and heavy feeling legs; legs felt like ran five miles but without the pain. Muscle fatigue would be a good way to describe it, but with some numbness; legs felt like ran five miles but without the pain. Muscle fatigue would be a good way to describe it, but with some numbness; some difficulty walking on right leg because it feels like leg is a bit asleep.; a hot and achy feeling in hands and leg.; a hot and achy feeling in hands and leg; bad Headache; lower back pain; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 08Apr2021 at 09:00(at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy to gelatin. The patient did not receive any medication within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021 the patient experienced lower back pain. On 08Apr2021 the patient experienced bad Headache. On 09Apr2021 at 07:00, the day after the vaccination, the patient experienced numbness and tingling in her 4th and 5th fingers on both hands and heavy feeling legs, she thought it was the start of muscle aches. The next morning, she woke up and her legs felt like she ran five miles but without the pain. Muscle fatigue would be a good way to describe it, but with some numbness. Every morning she woke up, her right leg and hands feel partially numb. she have some difficulty walking on her right leg because it feels like her leg is a bit asleep. Sometimes this alternate with a hot and achy feeling in her hands and leg. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event lower back pain was recovered on unknown date in Apr2021 and of the bad Headache, numbness and tingling in 4th and 5th fingers on both hands, heavy feeling legs, Muscle fatigue, numbness in leg, difficulty walking, and hot and achy feeling in hands and leg was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Muscle fatigue, Pain in extremity, Paraesthesia
Clinical narrative: numbness and tingling in 4th and 5th fingers on both hands and heavy feeling legs; numbness and tingling in 4th and 5th fingers on both hands and heavy feeling legs; numbness and tingling in 4th and 5th fingers on both hands and heavy feeling legs; legs felt like ran five miles but without the pain. Muscle fatigue would be a good way to describe it, but with some numbness; legs felt like ran five miles but without the pain. Muscle fatigue would be a good way to describe it, but with some numbness; some difficulty walking on right leg because it feels like leg is a bit asleep.; a hot and achy feeling in hands and leg.; a hot and achy feeling in hands and leg; bad Headache; lower back pain; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 08Apr2021 at 09:00(at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy to gelatin. The patient did not receive any medication within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021 the patient experienced lower back pain. On 08Apr2021 the patient experienced bad Headache. On 09Apr2021 at 07:00, the day after the vaccination, the patient experienced numbness and tingling in her 4th and 5th fingers on both hands and heavy feeling legs, she thought it was the start of muscle aches. The next morning, she woke up and her legs felt like she ran five miles but without the pain. Muscle fatigue would be a good way to describe it, but with some numbness. Every morning she woke up, her right leg and hands feel partially numb. she have some difficulty walking on her right leg because it feels like her leg is a bit asleep. Sometimes this alternate with a hot and achy feeling in her hands and leg. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event lower back pain was recovered on unknown date in Apr2021 and of the bad Headache, numbness and tingling in 4th and 5th fingers on both hands, heavy feeling legs, Muscle fatigue, numbness in leg, difficulty walking, and hot and achy feeling in hands and leg was not recovered.  No follow-up attempts are needed. No further information is expected.